- Home
- ARWR vs STNG Comparison
ARWR vs STNG Comparison
Compare ARWR & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- STNG
- Stock Information
- Founded
- ARWR 2003
- STNG 2009
- Country
- ARWR United States
- STNG Monaco
- Employees
- ARWR N/A
- STNG N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- STNG Marine Transportation
- Sector
- ARWR Health Care
- STNG Consumer Discretionary
- Exchange
- ARWR Nasdaq
- STNG Nasdaq
- Market Cap
- ARWR 2.5B
- STNG 3.1B
- IPO Year
- ARWR 1993
- STNG 2010
- Fundamental
- Price
- ARWR $30.07
- STNG $59.50
- Analyst Decision
- ARWR Strong Buy
- STNG Strong Buy
- Analyst Count
- ARWR 8
- STNG 4
- Target Price
- ARWR $47.75
- STNG $59.00
- AVG Volume (30 Days)
- ARWR 2.8M
- STNG 1.0M
- Earning Date
- ARWR 08-07-2025
- STNG 10-28-2025
- Dividend Yield
- ARWR N/A
- STNG 2.64%
- EPS Growth
- ARWR N/A
- STNG N/A
- EPS
- ARWR N/A
- STNG 7.37
- Revenue
- ARWR $572,976,000.00
- STNG $916,164,000.00
- Revenue This Year
- ARWR $21,619.52
- STNG N/A
- Revenue Next Year
- ARWR N/A
- STNG $2.28
- P/E Ratio
- ARWR N/A
- STNG $8.23
- Revenue Growth
- ARWR 2816.20
- STNG N/A
- 52 Week Low
- ARWR $9.57
- STNG $30.63
- 52 Week High
- ARWR $31.13
- STNG $74.67
- Technical
- Relative Strength Index (RSI)
- ARWR 72.77
- STNG 73.49
- Support Level
- ARWR $28.12
- STNG $56.26
- Resistance Level
- ARWR $30.40
- STNG $62.23
- Average True Range (ATR)
- ARWR 1.54
- STNG 1.65
- MACD
- ARWR 0.08
- STNG 0.48
- Stochastic Oscillator
- ARWR 88.87
- STNG 78.45
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.